מונטנגרו - קרואטית - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

druŠtvo za proizvodnju, posredovanje i promet "urion" d.o.o. podgorica - in vitro dijagnostička medicinska sredstva

מונטנגרו - קרואטית - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

druŠtvo za proizvodnju, posredovanje i promet "urion" d.o.o. podgorica - in vitro dijagnostička medicinska sredstva

מונטנגרו - קרואטית - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

druŠtvo za proizvodnju, posredovanje i promet "urion" d.o.o. podgorica - in vitro dijagnostička medicinska sredstva

מונטנגרו - קרואטית - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

"pdg professional development group" d.o.o. podgorica - bolnička, aparaturna oprema

מונטנגרו - קרואטית - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

druŠtvo sa ograniČenom odgovornoŠĆu "farmalab" d.o.o. podgorica - medicinska sredstva za jednokratnu upotrebu

קרואטיה - קרואטית - HALMED (Agencija za lijekove i medicinske proizvode)

iga d.o.o., split - kateter za mikrodijalizu u moždanom tkivu

האיחוד האירופי - קרואטית - EMA (European Medicines Agency)

sanofi b.v. - sutimlimab - hemolysis; anemia, hemolytic, autoimmune - imunosupresivi - enjaymo is indicated for the treatment of haemolytic anaemia in adult patients with cold agglutinin disease (cad).

האיחוד האירופי - קרואטית - EMA (European Medicines Agency)

sanofi b.v. - sevelamer - renal dialysis; hyperphosphatemia - svi ostali terapeutski proizvodi - renagel is indicated for the control of hyperphosphataemia in adult patients receiving  haemodialysis or peritoneal dialysis. renagel should be used within the context of a multiple therapeutic approach, which could include calcium supplements, 1,25 - dihydroxy vitamin d3 or one of its analogues to control the development of renal bone disease.

האיחוד האירופי - קרואטית - EMA (European Medicines Agency)

novavax cz, a.s. - sars cov-2 (original) recombinant spike protein, sars-cov-2 (omicron xbb.1.5) recombinant spike protein - covid-19 virus infection - covid-19 vaccines - nuvaxovid is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 12 years of age and older. korištenje ovog cjepiva mora se provoditi u skladu sa službenim preporukama. nuvaxovid xbb. 5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 12 years of age and older. korištenje ovog cjepiva mora se provoditi u skladu sa službenim preporukama.

האיחוד האירופי - קרואטית - EMA (European Medicines Agency)

kyowa kirin holdings b.v. - mogamulizumab - sezary syndrome; mycosis fungoides - antineoplastična sredstva - poteligeo indiciran za liječenje odraslih bolesnika s kandidijaza usne šupljine (mf) ili sindrom sézary (ss), koji je dobio barem jedan prije sistemske terapije.